SLShouxia Li

Shouxia Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shouxia Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Chaoyu Zhu

    Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Chaoyu Zhu

    Department of Endocrinology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Fei Hua

    Department of Endocrinology, The Third Affiliated Hospital of Soochow University, China

    1 shared publication
  • Fusong Jiang

    Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Fusong Jiang

    Department of Endocrinology and Metabolism, Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital, Shanghai, 200233, China.

    1 shared publication
  • Li Wei

    Department of Endocrinology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Low serum dehydroepiandrosterone sulfate is related to diabetic retinopathy in males with type 2 diabetes mellitus

    by Shouxia Li, Chaoyu Zhu, Fusong Jiang, Yuanyuan Xiao, Qianqian Wang, Wenjing Song, Qingge Gao, Xinyi Wang, Li Wei

    Objective: Androgens are increasingly recognized as important regulators of metabolic balance and vascular integrity. However, their relationship with diabetic retinopathy (DR) remains incompletely defined and appears to differ by sex. The present study aimed to examine the associations between circulating levels of total testosterone (TT), dehydroepiandrosterone sulfate (DHEAS), and androstenedione (ASD) and DR risk among individuals with type 2 diabetes mellitus (T2DM), with particular emphasis on gender-stratified analyses. Methods: This cross-sectional investigation analyzed 796 hospitalized T2DM cases. Serum concentrations of TT, DHEAS, and ASD were quantified using chemiluminescence immunoassays. Multivariable logistic regression was utilized to assess the associations between androgen levels and the presence of DR, with analyses conducted separately for men and women to account for sex-specific differences. Results: Among male participants, after comprehensive adjustment for potential confounding variables, serum DHEAS levels were independently and inversely linked with DR risk (tertile 3 vs. tertile 1: OR = 0.43, 95% CI: 0.23–0.82; P for trend = 0.007). Restricted cubic spline modeling demonstrated an approximately linear inverse dose-response relationship between DHEAS concentrations and DR risk (overall P < 0.001; nonlinear P = 0.193). No correlations were found between serum TT or ASD levels and DR in men. In female patients, an inverse relationship between TT and DR was attenuated and rendered nonsignificant after full multivariable adjustment, and neither DHEAS nor ASD showed a statistically significant association with DR risk. Conclusions: Lower serum DHEAS concentrations are independently linked with elevated DR risk in males with T2DM, suggesting a potential role for DHEAS in the pathophysiology of DR in males.

  • Open Access

    Exploring the potential mechanisms of OSBPL3 in metabolic dysfunction-associated steatotic liver disease by integrating bulk and single-cell RNA sequencing data

    by Qianqian Wang, Chaoyu Zhu, Yuanyuan Xiao, Xinyi Wang, Wenjing Song, Shouxia Li, Fusong Jiang, Li Wei, Fei Hua

    OSBPL3 is vital for fatty liver disease, but its immune mechanisms in metabolic dysfunction-associated steatotic liver disease (MASLD) are unclear. This study investigates these mechanisms for MASLD treatment insights. MASLD datasets from public databases were used. OSBPL3 expression was analyzed by t -test in GSE57425, and its function explored via GSEA. Key cell types were identified in GSE129516 by scRNA-seq, followed by cell-to-cell communication and pseudo-temporal analyses. OSBPL3 expression differed significantly between high-fat and normal diet groups ( P = .00048). It was enriched in the “oxidative phosphorylation” pathway, hinting at its role in energy metabolism and mitochondrial function in MASLD. Thirteen cell types were identified, with macrophages and monocytes as key types due to expression and cell percentage differences. Macrophages showed closer communication with granulocytes, fibroblasts, and erythrocytes in nonalcoholic steatohepatitis (NASH) diet samples. Macrophage and monocyte differentiation had 9 distinct states, with OSBPL3 highly expressed during metaphase. This study identified macrophages and monocytes as key cell types in OSBPL3’s mechanism in MASLD, offering valuable insights for targeted therapies.